Skip to main content
OpenTrials
Completed

NCT Number: NCT05577169

Incorporating Mind-body Skills With Diabetes Education in Adolescents With Type 1 Diabetes

Adolescence presents a challenging time for type 1 diabetes management, and despite a multitude of studies aimed at increasing disease compliance in this age group, none have been deemed superior. The purpose of this study is to incorporate mindfulness skills in with diabetes education sessions for adolescents with type 1 diabetes and study if this translates to improved outcomes in glycemic control, patient satisfaction, and mental wellness.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States

Loading trial locations.

About this study

This is a pilot study to learn if adding mind-body skills to diabetes education is useful in helping adolescents manage their type 1 diabetes. Specifically, the investigators will be studying adolescents aged 15-17 years old with uncontrolled diabetes defined by an A1c >9.0% who have also had the diagnosis of diabetes for at least 12 months. This study combines the teaching of mind-body skills with short virtual diabetes education sessions, in order to address both the direct needs of good diabetes management and the indirect needs of coping with diabetes-related stress and other external factors. The investigators will have two arms of the study - one receiving diabetes education with the addition of mind-body skills, and the other arm receiving only diabetes education. Sessions will be conducted virtually with 20-30 minutes of diabetes education, followed by 20-30 minutes of mind-body skills teaching in the respective arm. The study will consist of 10-12 weekly group sessions, with pre- and post-study questionnaires to evaluate mental and physical health. Participants will continue to attend their regular diabetes clinic appointments every three months. At the end of the study, participants will also partake in a short interview to gather feedback about their experience. The goals of this study are to evaluate the effect of mind-body skills as well as pilot test the feasibility and acceptability of such a project.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 15-17 years
  • Diagnosis of type 1 diabetes for at least 12 months
  • Uncontrolled diabetes with A1c at least 9.0%
  • Parent or guardian agrees for adolescent to participate

Exclusion criteria

  • Diagnosed cognitive disabilities
  • Other uncontrolled chronic diseases as assessed by PI
  • Inability to attend visits due to individual schedules

Treatment and study plan

Mind-body skills

Behavioral

The purpose of mind-body medicine is to use conscious thoughts and actions to positively impact autonomic responses from the brain as well as coping mechanisms for life's stresses. Examples of mind-body skills include deep breathing exercises, meditation, drawing, guided imagery, journaling, affirmations, and biofeedback.

Diabetes education

Behavioral

When children and adolescents are diagnosed with diabetes, education is typically focused on the parents; as our older adolescents prepare to transition to adult care with full responsibility of their health, the goal of short education sessions is to review the basics of T1D along with addressing each individual's needs and questions as they make this transition.

Primary outcomes

  1. Feasibility of intervention in the study population.

    Time frame: 12 months

    Feasibility of recruitment, retention of participants, and intervention completion. This will be measured by considering study participation rate, time to recruit, attendance, study retention rate, study completion rate, participant burden, and data completeness.

  2. Acceptability of intervention in the study population.

    Time frame: 12 months

    This will be measured by participant satisfaction surveys.

Secondary outcomes

  1. Hemoglobin A1c (HbA1c, %)

    Time frame: 12 months

    The change in HbA1c will be measured from baseline to 12 months.

Other outcomes

  1. Patient Health Questionnaire for Adolescents (PHQ-A)

    Time frame: 12 months

    Measure of general health and wellbeing. The change in the PHQ-A will be measured from baseline to 12 months.

  2. Screen for Childhood Anxiety Related Emotional Disorders (SCARED-5) questionnaire

    Time frame: 12 months

    The change in the SCARED-5 will be measured from baseline to 12 months.

  3. Problem Areas in Diabetes - Teens (PAID-T) questionnaire

    Time frame: 12 months

    The change in the PAID-T will be measured from baseline to 12 months.

  4. Peds QL Diabetes Module questionnaire

    Time frame: 12 months

    The change in the Peds QL Diabetes Module will be measured from baseline to 12 months.

  5. Mindful Attention Awareness Scale (MAAS) questionnaire for adolescents

    Time frame: 12 months

    The change in the MAAS will be measured from baseline to 12 months.

  6. Difficulties in Emotion Regulation Scale (DERS) questionnaire

    Time frame: 12 months

    The change in the DERS will be measured from baseline to 12 months.

  7. Child and Adolescent Social Support Scale (CASSS) questionnaire

    Time frame: 12 months

    The change in the parent and friends subscales of the CASSS will be measured from baseline to 12 months.

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Collaborators

  • Eli Lilly and Company

Registry information

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Oct 13, 2022
Registry last updated
Apr 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.